The clinical trial site management organizations market has seen considerable growth due to a variety of factors.
• The clinical trial site management organizations market has seen significant growth in recent years. It will grow from $6.71 billion in 2024 to $7.29 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%.
This growth is attributed to the increasing demand for drug discovery, the high prevalence of chronic diseases, the growing number of clinical trials for new drugs and therapies, and the booming pharmaceutical industry.
The clinical trial site management organizations market is expected to maintain its strong growth trajectory in upcoming years.
• The clinical trial site management organizations market is expected to grow to $9.98 billion by 2029 at an 8.2% CAGR. Growth is driven by increasing complexities in drug development and the outsourcing trend to CROs. Trends include decentralized trials, emphasis on therapeutic areas, and technological advancements.
The rising demand for drug discoveries is expected to fuel the clinical trial site management organization market. The need for new medications, driven by emerging diseases and aging populations, is accelerating pharmaceutical research. Clinical trial site management ensures efficient drug discovery by facilitating compliance, data collection, and patient recruitment. In 2023, 69 new active substances were approved globally, reflecting increased drug discovery efforts.
The clinical trial site management organizations market covered in this report is segmented –
1) By Services: Site Management, Project Management, Regulatory, Onsite monitoring
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Therapeutic Area: Oncology, Cardiology, Central Nervous System (CNS), Pain Management, Endocrine, Other Therapeutic Areas
Subsegments:
1) By Site Management: Site Selection And Feasibility, Patient Recruitment And Retention, Site Coordination And Administration
2) By Project Management: Project Planning And Scheduling, Budget And Resource Management, Risk Management And Compliance
3) By Regulatory: Regulatory Submissions And Approvals, Ethics And Institutional Review Board (IRB) Submissions, Regulatory Compliance And Audits
4) By Onsite Monitoring: Site Visits And Inspections, Data Quality Monitoring, Safety And Protocol Compliance Monitoring
Companies in the clinical trial site management organizations market are integrating AI into virtual trial platforms to optimize recruitment and engagement. For instance, in October 2023, Elligo Health Research partnered with Avallano to launch myTrialsConnect, an AI-powered platform that helps optimize clinical trial recruitment by automating participant enrollment and improving patient interaction throughout the trial process.
Major companies operating in the clinical trial site management organizations market are:
• IQVIA Holdings Inc.
• ICON plc
• PPD Inc.
• SGS SA
• Syneos Health Inc.
• Charles River Laboratories International Inc.
• PAREXEL International Corporation
• Medpace Holdings Inc.
• Premier Research Group Limited
• WIRB-Copernicus Group
• Worldwide Clinical Trials Inc.
• ClinChoice Inc.
• Clinigen Group plc
• Precision for Medicine Inc.
• Synexus Clinical Research
• Celerion Inc.
• Sarah Cannon Research Institute
• Clinipace Worldwide Inc.
• Ergomed plc
• Rho Federal Systems Division Inc.
• Veristat LLC
• CTI Clinical Trial & Consulting Services
• Clinedge
• FOMAT Medical Research INC.
• Grand Pacific CRO
• Xylem CRO
• Access Clinical Research LLC
• KV Consulting Corporation
• Aurum Clinical Research
• EthosExcel Inc.
Asia-Pacific was the largest region in the clinical trial site management organizations market in 2023. The regions covered in the clinical trial site management organizations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.